dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Faura Llorens, Julia |
dc.contributor.author | Bustamante Rangel, Alejandro |
dc.contributor.author | Miro Mur, Francesc |
dc.contributor.author | Montaner Villalonga, Joan |
dc.date.accessioned | 2022-01-14T10:58:12Z |
dc.date.available | 2022-01-14T10:58:12Z |
dc.date.issued | 2021-06-06 |
dc.identifier.citation | Faura J, Bustamante A, Miró-Mur F, Montaner J. Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections. J Neuroinflammation. 2021 Jun 6;18:127. |
dc.identifier.issn | 1742-2094 |
dc.identifier.uri | https://hdl.handle.net/11351/6801 |
dc.description | Immunosupressió; Infecció; Ictus |
dc.description.sponsorship | This project received funding from Instituto de Salud Carlos III (ISCIII) [PI17/02130], co-financed by the European Regional Development Fund (FEDER), and from Fundació La Marató de TV3 [201706]. Neurovascular Research Laboratory takes part into the Spanish stroke research network INVICTUS+ [RD16/0019/0021]. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Journal of Neuroinflammation;18 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Malalties cerebrovasculars - Tractament |
dc.subject | Medicaments immunosupressors - Ús terapèutic |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Stroke |
dc.subject.mesh | Immunosuppressive Agents |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Treatment Outcome |
dc.title | Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12974-021-02177-0 |
dc.subject.decs | accidente cerebrovascular |
dc.subject.decs | inmunosupresores |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1186/s12974-021-02177-0 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Faura J] Laboratori de Recerca Neurovascular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bustamante A] Stroke Unit, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain. [Miró-Mur F] Unitat de Recerca Autoimmune Sistèmica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Montaner J] Laboratori de Recerca Neurovascular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen de la Macarena, Seville, Spain |
dc.identifier.pmid | 34092245 |
dc.identifier.wos | 000660897300001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI17%2F02130 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0019%2F0021 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |